Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
Go back to Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 53.53 +0.57 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.96 | 52 Week High | $3.48 | |||
| Open | $53.27 | 52 Week Low | $0.80 | |||
| Day High | $53.71 | P/E | N/A | |||
| Day Low | $52.89 | EPS | $-1.54 | |||
| Volume | 3,115,248 | |||||
